Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (SHA:605016)
China flag China · Delayed Price · Currency is CNY
26.29
-0.42 (-1.57%)
Apr 17, 2026, 3:00 PM CST

SHA:605016 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
1,3791,107854.14696.18638.52
Other Revenue
-4514.1225.7114.83
1,3791,152868.26721.89653.36
Revenue Growth (YoY)
19.75%32.64%20.28%10.49%30.77%
Cost of Revenue
803.18764.89584.2493.41471.72
Gross Profit
575.87386.76284.06228.49181.64
Selling, General & Admin
79.8667.5447.7745.0540.35
Research & Development
48.8244.4632.5627.0323.26
Other Operating Expenses
-1.319.687.615.995.67
Operating Expenses
127.37127.9290.6182.8171.65
Operating Income
448.5258.84193.45145.68109.98
Interest Expense
--2.66-2.25-0.07-1.04
Interest & Investment Income
3.459.6112.1412.765.04
Currency Exchange Gain (Loss)
-8.174.1310.28-2.76
Other Non Operating Income (Expenses)
-10.79-0.43-0.21-0.13-0.14
EBT Excluding Unusual Items
441.16273.53207.27168.52111.09
Gain (Loss) on Sale of Investments
-0.791.272.703.35
Gain (Loss) on Sale of Assets
-5.55-0.39-2.13-3.15-1.26
Asset Writedown
-2.55----1.73
Other Unusual Items
-10.8913.687.717.32
Pretax Income
432.27285.31221.52173.09118.77
Income Tax Expense
63.7239.7128.5222.3414.29
Net Income
368.55245.6193150.75104.48
Net Income to Common
368.55245.6193150.75104.48
Net Income Growth
50.06%27.26%28.02%44.29%9.34%
Shares Outstanding (Basic)
419420418418385
Shares Outstanding (Diluted)
419420418418385
Shares Change (YoY)
-0.31%0.46%0.12%8.63%22.70%
EPS (Basic)
0.880.580.460.360.27
EPS (Diluted)
0.880.580.460.360.27
EPS Growth
50.53%26.67%27.88%32.83%-10.89%
Free Cash Flow
-161.3519.09-117.34-25.7840.38
Free Cash Flow Per Share
-0.390.04-0.28-0.060.10
Dividend Per Share
-0.1460.1420.0720.026
Dividend Growth
-2.96%97.50%180.86%-
Gross Margin
41.76%33.58%32.72%31.65%27.80%
Operating Margin
32.52%22.48%22.28%20.18%16.83%
Profit Margin
26.72%21.33%22.23%20.88%15.99%
Free Cash Flow Margin
-11.70%1.66%-13.51%-3.57%6.18%
EBITDA
545.38334.22238.38192.42156.51
EBITDA Margin
39.55%29.02%27.46%26.66%23.96%
D&A For EBITDA
96.8875.3844.9346.7546.53
EBIT
448.5258.84193.45145.68109.98
EBIT Margin
32.52%22.48%22.28%20.18%16.83%
Effective Tax Rate
14.74%13.92%12.88%12.91%12.04%
Revenue as Reported
-1,152868.26721.89653.36
Advertising Expenses
-3.482.91.131.25
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.